万和证券股份有限公司关于上海荣泰健康科技股份有限公司2025年持续督导工作现场检查报告 截至2026年1月16日收盘，荣泰健康(603579)报收于26.63元，下跌3.9%，换手率5.93%，成交量12.05万 手，成交额3.24亿元。 当日关注点 交易信息汇总资金流向 1月16日主力资金净流出4993.68万元，占总成交额15.43%；游资资金净流入559.0万元，占总成交额 1.73%；散户资金净流入4434.69万元，占总成交额13.7%。 公司公告汇总 万和证券作为保荐机构，于2026年1月7日至8日对荣泰健康进行了2025年持续督导现场检查。检查内容 包括公司治理、内部控制、信息披露、募集资金使用、关联交易、经营状况等方面。检查结果显示，公 司治理结构完善，信息披露合规，募集资金使用规范，未发现控股股东违规占用资金情形，经营状况正 常。保荐机构认为公司各项运作符合监管要求，未发现需向证监会和上交所报告的重大事项。 以上内容为证券之星据公开信息整理，由AI算法生成（网信算备310104345710301240019号），不构成 投资建议。 来自交易信息汇总：1月16日主力资金净流出4993.68万元 ...

Core Viewpoint - Rongtai Health (603579) experienced a decline in stock price, closing at 26.63 yuan, down 3.34% from the previous week, with a market capitalization of 5.415 billion yuan [1] Company Announcements - Wanhe Securities conducted a site inspection for the 2025 continuous supervision of Rongtai Health from January 7 to 8, 2026, confirming compliance in corporate governance and information disclosure [1] - The inspection covered aspects such as corporate governance, internal controls, information disclosure, use of raised funds, related party transactions, and operational status, with results indicating a well-structured governance and normal operational conditions [1] - No violations were found regarding the controlling shareholder's use of funds, and the operations were deemed compliant with regulatory requirements, with no significant matters needing to be reported to the CSRC and SSE [1]

Group 1 - The core stock price of Rongtai Health (603579) closed at 27.71 yuan on January 15, 2026, with a slight increase of 0.33% and a turnover rate of 6.9% [1] - The trading volume was 140,400 shares, resulting in a total transaction amount of 392 million yuan [1] Group 2 - On January 15, 2026, the net inflow of main funds was 26.57 million yuan, indicating a high level of interest from institutional investors [2][3] - Retail investors experienced a net outflow of 21.91 million yuan, while speculative funds saw a net outflow of 4.66 million yuan [2] - Wanhe Securities conducted a site inspection for the 2025 continuous supervision of Rongtai Health from January 7 to 8, 2026, confirming that the company's governance structure is sound and information disclosure is compliant [2][3] - The inspection found no violations regarding the use of raised funds by the controlling shareholder, and the company's operational status was deemed normal [2]

截至2026年1月15日收盘，荣泰健康（603579）报收于27.71元，较前一交易日上涨0.33%，最新总市值 为56.35亿元。该股当日开盘27.47元，最高28.51元，最低27.18元，成交额达3.92亿元，换手率为6.9%。 公司近日发布公告，万和证券股份有限公司作为保荐机构，于2026年1月7日至8日对荣泰健康进行了 2025年持续督导工作现场检查。公告显示，检查内容涵盖公司治理、内部控制、信息披露、募集资金使 用、关联交易及经营状况等方面。检查结果表明，公司治理结构完善，信息披露合规，募集资金使用规 范，未发现控股股东违规占用资金的情形，整体经营状况正常。保荐机构认为公司各项运作符合监管要 求，未发现需向证监会和上交所报告的重大事项。 最新公告列表 《万和证券股份有限公司关于上海荣泰健康科技股份有限公司2025年持续督导工作现场检查报 告》 以上内容为证券之星据公开信息整理，由AI算法生成（网信算备310104345710301240019号），不构成 投资建议。 ...

4、查阅上市公司募集资金使用凭证、募集资金专户银行对账单、募集资金 使用台账等资料; 万和证券股份有限公司关于上海荣泰健康科技股份有限公司 2025 年持续督导工作现场检查报告 上海证券交易所: 经中国证券监督管理委员会《关于核准上海荣泰健康科技股份有限公司公开 发行可转换公司债券的批复》(证监许可「202012139 号)核准,上海荣泰健康科 技股份有限公司(以下简称"荣泰健康""上市公司""公司")公开发行 600 万 张 A 股可转换公司债券(每张面值 100 元人民币),募集资金总额为人民币 60,000.00 万元,募集资金净额 59.398.23 万元。上述募集资金已于 2020 年 11 月 5 日全部到位,并经中汇会计师事务所(特殊普通合伙)出具中汇会验[202016483 号验资报告验证。 万和证券股份有限公司(以下简称"万和证券""保荐机构")作为荣泰健康 2020 年公开发行可转换公司债券项目的保荐机构,根据《证券发行上市保荐业 务管理办法》以及《上海证券交易所上市公司自律监管指引第 11 号 --- 持续督 导》等相关法规规定,于 2026年1月7日至 8 日对公司进行了现场检查,现将 ...

Core Viewpoint - The other home appliance sector experienced a decline of 1.6% on January 15, with Aojiahua leading the drop. The Shanghai Composite Index closed at 4112.6, down 0.33%, while the Shenzhen Component Index closed at 14306.73, up 0.41% [1]. Group 1: Market Performance - The closing prices and performance of key stocks in the other home appliance sector are as follows: - Rongtai Health (603579) closed at 27.71, with a slight increase of 0.33% and a trading volume of 140,400 shares, totaling a transaction value of 392 million yuan [1]. - Rongjie Health (300247) closed at 5.34, down 2.91% with a trading volume of 356,400 shares, totaling a transaction value of 190 million yuan [1]. - Aojiahua (002614) closed at 7.10, down 3.14% with a trading volume of 303,400 shares, totaling a transaction value of 217 million yuan [1]. Group 2: Capital Flow - The net capital flow in the other home appliance sector showed a net outflow of 23.11 million yuan from main funds, while retail investors saw a net inflow of 22.61 million yuan [1]. - Specific capital flows for key stocks are as follows: - Rongtai Health had a net inflow of 26.57 million yuan from main funds, but a net outflow of 21.91 million yuan from retail investors [1]. - Rongjie Health experienced a net outflow of 11.53 million yuan from main funds, with a net inflow of 13.54 million yuan from retail investors [1]. - Aojiahua faced a significant net outflow of 38.15 million yuan from main funds, while retail investors contributed a net inflow of 30.97 million yuan [1].

Group 1 - The core point of the article highlights the performance of the home appliance sector, which saw an increase of 0.47% on the previous trading day, with Rongtai Health leading the gains [1] - The Shanghai Composite Index closed at 4126.09, down by 0.31%, while the Shenzhen Component Index closed at 14248.6, up by 0.56% [1] - Specific stock performances within the home appliance sector include Rongtai Health at a closing price of 27.62 with a gain of 1.21%, and Aojiahua at 7.33 with a decline of 0.41% [1] Group 2 - The net capital flow in the home appliance sector showed a net outflow of 59.6642 million yuan from institutional investors, while retail investors had a net inflow of 62.9372 million yuan [1] - Detailed capital flow for individual stocks indicates that Aojiahua experienced a net outflow of 5.6268 million yuan, while Rongtai Health had a net outflow of 38.5355 million yuan [1] - The trading volume for Rongtai Health was 177,400 shares, with a total transaction amount of 4.89 billion yuan [1]

Group 1 - The other home appliance sector declined by 0.33% compared to the previous trading day, with Rongtai Health leading the decline [1] - The Shanghai Composite Index closed at 4138.76, down 0.64%, while the Shenzhen Component Index closed at 14169.4, down 1.37% [1] - Key stock performances in the other home appliance sector included Rongjie Health at 5.49 with a rise of 2.81%, Aojiahua at 7.36 with a decline of 0.67%, and Rongtai Health at 27.29 with a drop of 2.50% [1] Group 2 - The net outflow of main funds in the other home appliance sector was 94.47 million yuan, while retail funds saw a net inflow of 42.29 million yuan [1] - Detailed fund flow for key stocks showed Rongjie Health with a net inflow of 13.50 million yuan, Aojiahua with a net outflow of 6.50 million yuan, and Rongtai Health with a significant net outflow of 90.67 million yuan [1]

Group 1 - The other home appliance sector increased by 1.69% compared to the previous trading day, with Rongjie Health leading the gains [1] - On January 12, the Shanghai Composite Index closed at 4165.29, up 1.09%, while the Shenzhen Component Index closed at 14366.91, up 1.75% [1] - Key stocks in the other home appliance sector showed varied performance, with Rongjie Health closing at 5.34, up 2.50%, and Rongtai Health at 27.99, up 1.60% [1] Group 2 - The net outflow of main funds in the other home appliance sector was 22.98 million yuan, while retail funds saw a net outflow of 2.38 million yuan [1] - The table indicates that Rongtai Health had a main fund net inflow of 8.33 million yuan, while Rongjie Health experienced a net outflow of 18.06 million yuan [1] - Retail investors showed a net inflow of 14.89 million yuan in Rongjie Health, despite the overall net outflow in the sector [1]

Core Viewpoint - Shanghai Rongtai Health Technology Co., Ltd. plans to acquire 21% equity in Shanghai Youmo Youyang Health Technology Co., Ltd. for 42 million yuan, which will allow the company to control 56.50% of the voting rights post-transaction, thus making it a subsidiary [2][4][11]. Group 1: Transaction Overview - The company intends to purchase 21% equity from shareholders of Youmo Youyang, with a total transaction price based on an asset valuation of 210.08 million yuan [4][15]. - The transaction has been approved by the company's board and does not require shareholder approval [3][40]. - The transaction is classified as a related party transaction due to the agreement with a shareholder, Zeng Biyan [2][4]. Group 2: Financial and Operational Impact - The acquisition is expected to enhance the company's competitive edge in the small massage appliance market, which is less affected by economic cycles [12][37]. - Youmo Youyang has shown significant growth potential, with its profitability improving in 2025 compared to 2024, indicating a strong financial outlook [13][38]. - The transaction will allow the company to consolidate its financials, improving revenue and profitability metrics [13][38]. Group 3: Valuation and Pricing - The valuation of Youmo Youyang was conducted using both asset-based and income approaches, with the latter deemed more reflective of the company's value due to its unique market position [16][18]. - The assessed market value of Youmo Youyang was 210.08 million yuan, with an appreciation of 171.52 million yuan, resulting in a valuation increase rate of 444.88% [16][19]. Group 4: Governance and Control - Post-transaction, the company will appoint three directors to Youmo Youyang's board, ensuring a 50% representation [11]. - The agreement with Zeng Biyan ensures aligned voting in shareholder meetings, solidifying control over Youmo Youyang [27][29]. Group 5: Compliance and Approval - The transaction has been reviewed and approved by the independent directors and the board, adhering to relevant regulations [40]. - No prior related transactions occurred between the company and the transaction parties in the last 12 months [3][40].